OpenVSafe by OpenVAERS
Search V-safe

PSM-41278-12243

2 vaccinations 6 coded responses 25 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
852 / AZ
Registered
2022-01-21
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-01-21
    Registered in v-safe
  2. 2022-01-21
    Dose 1 — Pfizer-BioNTech
  3. 2022-01-21
    Health check-in — day 0, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  4. 2022-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Itching · None
    Adult check-in
  5. 2022-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness
    Adult check-in
  6. 2022-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2022-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · Headache, Fatigue or tiredness
    Adult check-in
  8. 2022-01-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Anxiety — Feeling: Good · Fatigue or tiredness
    Free text: Anxiety
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Joint pains, Fatigue or tiredness
    Adult check-in
  10. 2022-01-28
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  11. 2022-02-05
    Survey response — day 14, dose 1
    MedDRA: Headache, Rhinorrhoea — Feeling: Good
    Free text: Runny nose and constant headaches.
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-02-12
    Dose 2 — Pfizer-BioNTech
  13. 2022-02-12
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  14. 2022-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tiredness
    Adult check-in
  15. 2022-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  16. 2022-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  17. 2022-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Joint pains
    Adult check-in
  18. 2022-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Joint pains
    Adult check-in
  19. 2022-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Joint pains, Muscle or body aches
    Adult check-in
  20. 2022-02-19
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches
    Adult check-in
  21. 2022-02-26
    Survey response — day 14, dose 2
    MedDRA: Dizziness, Headache — Feeling: Good
    Free text: Dizziness and headaches
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-03-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2022-03-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2022-03-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2022-03-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-05-14
    Survey response — 3 months, dose 2
    MedDRA: Arthralgia, Headache, Pain — Feeling: Fair
    Free text: Entire body aches, joint pain and ocassional headaches
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-08-13
    Survey response — 6 months, dose 2
    MedDRA: Pain — Feeling: Fair
    Free text: Constant Body aches
    MedDRA releases: 2024-11 · check-in free text available
  28. 2023-02-12
    Survey response — 12 months, dose 2
    MedDRA: Cough, Laryngitis, Nasal congestion, Oropharyngeal pain — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  29. 2023-02-12
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  30. 2023-02-13

Vaccinations

DoseDateManufacturerCo-administered
12022-01-21Pfizer-BioNTech No
22022-02-12Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 11 — days 1–6 daily, dose 1

2022-01-26

Systemic reaction (other): Anxiety

Release 11 — day 14, dose 1

2022-02-05

Symptoms: Runny nose and constant headaches.

Release 11 — day 14, dose 2

2022-02-26

Symptoms: Dizziness and headaches

Release 11 — 3 months, dose 2

2022-05-14

Symptoms: Entire body aches, joint pain and ocassional headaches

Release 12 — 6 months, dose 2

2022-08-13

Symptoms: Constant Body aches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia · · ✓
SDCough · · ✓
SDDizziness · · ✓
SDHeadache · · ✓
SDLaryngitis · · ✓
SDNasal congestion · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDRhinorrhoea · · ✓
SROAnxiety · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release